Which has grown faster, RIGL or SIBN?

Over the past five years, SIBN grew revenue faster — RIGL at a 13.94% CAGR versus SIBN at 20.20%.

Is RIGL or SIBN more profitable?

RIGL runs the higher net margin — RIGL at 116.30% versus SIBN at -6.85%.

How have RIGL and SIBN total returns compared?

Over the past 5 years, RIGL delivered 6.25% and SIBN delivered -1.46% annualized total return. Past performance doesn't predict future results.

Rigel Pharmaceuticals, Inc. (RIGL) vs SI-BONE, Inc. (SIBN)

A side-by-side comparison of Rigel Pharmaceuticals, Inc. and SI-BONE, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

RIGL

Rigel Pharmaceuticals, Inc.

$853M

$46.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SIBN

SI-BONE, Inc.

$867M

$19.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — RIGL vs SIBN

growth of $100 · dividends reinvested · last 8y

RIGL +54.2% (+5.6%/yr)SIBN -1.2% (-0.2%/yr)RIGL compounded faster over this window

RIGL SIBN

RIGL vs SIBN: by the numbers

•SIBN is the larger company ($867M vs $853M market cap).
•RIGL is profitable (116.30% net margin) while SIBN runs a net loss (-6.85%).
•SIBN grew revenue faster over the past five years (20.20% vs 13.94% CAGR).

Metrics side by side

Valuation

Metric	RIGL	SIBN
P/E ratio	2.83	N/A
Forward P/E	13.44	N/A
P/S ratio	3.08	4.06
P/B ratio	2.01	4.75
EV / EBITDA	9.28	N/A
FCF yield	9.31%	N/A

Profitability

Metric	RIGL	SIBN
Gross margin	91.39%	79.53%
Operating margin	42.63%	-8.31%
Net margin	116.30%	-6.85%
ROE	75.67%	-8.03%
ROIC	18.72%	-7.88%

Growth (annualized)

Metric	RIGL	SIBN
Revenue CAGR (5Y)	13.94%	20.20%
Total return CAGR (5Y)	6.25%	-1.46%

Frequently asked

Which has grown faster, RIGL or SIBN?: Over the past five years, SIBN grew revenue faster — RIGL at a 13.94% CAGR versus SIBN at 20.20%.
Is RIGL or SIBN more profitable?: RIGL runs the higher net margin — RIGL at 116.30% versus SIBN at -6.85%.
How have RIGL and SIBN total returns compared?: Over the past 5 years, RIGL delivered 6.25% and SIBN delivered -1.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full RIGL analysis Full SIBN analysis Interactive comparison tool

Dig into the metrics

Rigel Pharmaceuticals P/E ratio Rigel Pharmaceuticals ROE SI-BONE ROE Rigel Pharmaceuticals operating margin SI-BONE operating margin Rigel Pharmaceuticals revenue growth SI-BONE revenue growth Rigel Pharmaceuticals free cash flow SI-BONE free cash flow

Rigel Pharmaceuticals & SI-BONE appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.